A carregar...
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
As of June 10th 2020 about 7.2 million individuals have tested positive for, and more than 410,000 have died due to COVID-19. In this review we outline the pathophysiology that underpins the potential use of anti-rheumatic therapies for severe COVID-19 infection and summarize the current evidence re...
Na minha lista:
| Publicado no: | Rheumatol Int |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7353833/ https://ncbi.nlm.nih.gov/pubmed/32654078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00296-020-04629-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|